Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Lag EstimatesZacks Investment Research • 05/06/25
Jazz Pharmaceuticals Announces First Quarter 2025 Financial Results and Updates 2025 Financial GuidancePRNewsWire • 05/06/25
Jazz Pharmaceuticals to Participate in the BofA Securities 2025 Healthcare ConferencePRNewsWire • 04/30/25
Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 04/29/25
Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract CancerPRNewsWire • 04/25/25
Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse GliomaPRNewsWire • 04/23/25
Buy 5 High ROE Stocks as Markets Break Tariff-Induced Losing StreakZacks Investment Research • 04/23/25
JAZZ vs. HRMY: Which Neuroscience Drugmaker Is the Stronger Play?Zacks Investment Research • 04/21/25
Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play OutSeeking Alpha • 04/09/25
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare ConferencePRNewsWire • 03/26/25